Stockholders to Receive $18.50 Per Share in Cash Representing a 26% Premium to 60-day Volume-Weighted Average Price Transaction to Strengthen Simulations Plus and Accelerate Growth Through Anticipated Combination with Chemical Computing Group RESEARCH TRIANGLE PARK, N.C. -- Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug [...]

Amsbio has expanded its diverse range of recombinant and monoclonal antibodies to include over 10,000 new validated monospecific products in 15,000 formulations to support research in cancer, immunology, neuroscience, and signal transduction. Every antibody in the new catalogue has been subject to rigorous validation technologies to confirm that they selectively recognize their intended targets across applications such as immunohistochemistry, western [...]

Strengthens Board with experienced industry executive, specializing in strategic planning, organizational leadership and commercial execution Cambridge, UK – Broken String Biosciences, a biotechnology company enabling gene editing teams to accelerate development of safer, more effective genetic medicines, today announced the appointment of Bruce Eaton, PhD as Chairman of the Board, with immediate effect. The appointment aligns with the [...]

BRAMPTON, ON - The Stevens Company Limited, a premier distributor of medical supplies for nearly two centuries, announced a major national expansion into the Canadian laboratory market. The strategic move directly challenges the current reliance on U.S. distributors by offering a customer-first, locally owned alternative with dedicated resources, enhanced specialty expertise, and a broader portfolio [...]

AUSTIN, Texas -- Astrotech Corporation (Nasdaq: ASTC) ("Astrotech" or the "Company") today announced that its Board of Directors has approved a potential sale process of its 1st Detect Corporation subsidiary ("1st Detect"), developer of the TRACER 1000 mass spectrometry-based explosives and narcotics trace detection ("ETD") platform. The TRACER 1000 is the only mass spectrometry ETD [...]

Collaboration with Leiden University Medical Center (LUMC) will explore application of electronic genome mapping (EGM) in facioscapulohumeral muscular dystrophy (FSHD) Poster presentation today at the European Society of Human Genetics (ESHG) 2026 Annual Meeting demonstrates ability of OhmX™ Platform to detect repeat expansion assays via EGM, optimized with CRISPR/Cas9 PROVIDENCE, R.I. -- Nabsys 2.0, LLC (Nabsys), [...]

Planned gene expression assay launches and high-multiplex capabilities are expected to expand QIAcuity into one of the largest molecular biology application areas Expanded Cell and Gene Therapy offerings and workflow automation capabilities strengthen the QIAcuity digital PCR ecosystem New software capabilities support standardized analysis and reporting across digital PCR workflows VENLO, Netherlands & GERMANTOWN, Md. [...]

Founded by the team who created the field of generative genomics, Radical Numerics' Seed funding will accelerate its mission to advance biological design for human health and build the biodefenses to protect it. SAN FRANCISCO -- Radical Numerics, an AI research lab building general biological intelligence, today announced its launch with $50 million in seed [...]

Partnership expands access to next-generation protein quantitation technology across Japan's biopharmaceutical and life sciences markets BILLERICA, Mass. -- Nirrin Technologies, a developer of analytical tools designed to transform bioprocessing workflows, today announced the appointment of S.T. Japan as its exclusive distribution partner for the TALOS™ protein quantitation system in Japan. S.T. Japan, a specialized provider [...]

Oxford, UK, and Oslo, Norway – Oxford Nanopore Technologies and MATRIX, Norway’s national cancer research centre, today announced the expansion of their collaboration to implement Oxford Nanopore sequencing for national central nervous system (CNS) tumour classification. Following successful clinical evaluation, the programme will now integrate the Oxford Nanopore-based approach into Norway’s National Infrastructure for Precision Diagnostics [...]